Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market
Holding INBX?
Track your performance easily

Inhibrx Biosciences Inc (INBX) Ownership - Who Owns Inhibrx Biosciences Inc?

16 Followers

Inhibrx Biosciences Inc (INBX) Ownership Overview

26.98%5.95%0.66%7.05%59.36%
26.98% Insiders
0.66% Other Institutional Investors
7.05% ETFs
59.36% Public Companies and Individual Investors
The ownership structure of Inhibrx Biosciences Inc (INBX) stock is a mix of institutional, retail, and individual investors. Approximately 13.66% of the company’s stock is owned by Institutional Investors, 26.98% is owned by Insiders, and 59.36% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 07, 2024
xxxxxxxxxxxxx
$100005
Sep 16, 2024
Mark Lappe
Ceo,director
xxxxxxxxxxxxx
$629117
Sep 12, 2024
xxxxxxxxxxxxx
$99992
Sep 10, 2024
Mark Lappe
Ceo,director
xxxxxxxxxxxxx
$671150

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$15077248
Jun 30, 2024
xxxxxxxxxxxxx
$25331779

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,787,705Institution12.35%28,603,280
1,157,926Insider8.00%18,526,816
1,093,860Insider7.56%17,501,760
1,064,026Institution7.35%17,024,416
925,413Insider6.39%14,806,608
500,299Institution3.46%8,004,784
473,888Insider3.27%7,582,208
440,123Institution3.04%7,041,968
403,281Institution2.79%6,452,496
224,564Insider1.55%3,593,024

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
403,281Institution2.79%6,452,496
116,108Institution0.80%1,857,728
66,166Institution0.46%1,058,656
55,338Institution0.38%885,408
51,472Institution0.36%823,552
49,627Institution0.34%794,032
24,513Institution0.17%392,208
24,228Institution0.17%387,648
16,050Institution0.11%256,800
11,064Institution0.08%177,024

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
337,352Institution2.33%5,282,932
317,829Institution2.20%5,085,264
99,212Institution0.69%1,553,660
64,842Institution0.45%1,037,472
53,164Institution0.37%832,548
49,345Institution0.34%789,520
26,273Institution0.18%420,368
23,001Institution0.16%372,846
11,850Institution0.08%185,571
11,132Institution0.08%178,112

FAQ

Who Owns Inhibrx Biosciences Inc (INBX)?
According to the latest TipRanks data, approximately 0.66% of the company's stock is held by institutional investors, 26.98% is held by insiders, and 59.36% is held by retail investors.
    What percentage of Inhibrx Biosciences Inc (INBX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.66% of Inhibrx Biosciences Inc (INBX) stock is held by institutional investors.
      What percentage of Inhibrx Biosciences Inc (INBX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 59.36% of Inhibrx Biosciences Inc (INBX) stock is held by retail investors.
        Who owns the most shares of Inhibrx Biosciences Inc (INBX)?
        Andreas Halvorsen owns the most shares of Inhibrx Biosciences Inc (INBX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis